Safety and efficacy trial of adipose-tissue derived oral preparation V-6 Immunitor (V-6): results of open-label, two-month, follow-up study

Por Jirathitikal Vichai, Bourinbaiar Aldar S
Publicado em 2010-02-01

Safety and efficacy trial of adipose-tissue derived oral preparation V-6 Immunitor (V-6): results of open-label, two-month, follow-up study

Por Bourinbaiar, Aldar S, Jirathitikal, Vichai
Publicado em 2010

Serodeconversion of HIV Antibody-Positive AIDS Patients Following Treatment with V-1 Immunitor

Por Metadilogkul, Orapun, Jirathitikal, Vichai, Bourinbaiar, Aldar S.
Publicado em 2009

Pilot trial of oral therapeutic HIV vaccine, V-1 Immunitor, on HIV and HIV/HCV patients in Russia

Por Bourinbaiar, Aldar, Orlovsky, Vladimir, Jirathitikal, Vichai, Metadilogkul, Orapun, Dmitry, Popov
Publicado em 2010

Phase IIb randomized trial of adjunct immunotherapy in patients with first-diagnosed tuberculosis, relapsed and multi-drug-resistant (MDR) TB

Por Butov, Dmitry A, Pashkov, Yuri N, Stepanenko, Anna L, Choporova, Aleksandra I, Butova, Tanya S, Batdelger, Dendev, Jirathitikal, Vichai, Bourinbaiar, Aldar S, Zaitzeva, Svetlana I
Publicado em 2011

Immunotherapy of liver cancer with hepcortespenlisimut-L: open-label Phase II clinical study in patients with advanced HCC

Por Tarakanovskaya, Marina G, Chinburen, Jigjidsuren, Purevsuren, Genden, Munkhzaya, Chogsom, Batchuluun, Purev, Bat-Ireedui, Purev, Dandii, Dorjiin, Oyungerel, Dandii, Kutsyna, Galyna A, Bain, Allen I, Jirathitikal, Vichai, Bourinbaiar, Aldar S
Publicado no J Immunother Cancer (2015)

Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7)

Por Efremenko, Yuri V, Butov, Dmytro A, Prihoda, Natalia D, Zaitzeva, Svetlana I, Yurchenko, Larisa V, Sokolenko, Nina I, Butova, Tetyana S, Stepanenko, Anna L, Kutsyna, Galyna A, Jirathitikal, Vichai, Bourinbaiar, Aldar S
Publicado em 2013

Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Por Tarakanovskaya, Marina G, Chinburen, Jigjidsuren, Batchuluun, Purev, Munkhzaya, Chogsom, Purevsuren, Genden, Dandii, Dorjiin, Hulan, Tsogkhuu, Oyungerel, Dandii, Kutsyna, Galyna A, Reid, Alan A, Borisova, Vika, Bain, Allen I, Jirathitikal, Vichai, Bourinbaiar, Aldar S
Publicado no J Hepatocell Carcinoma (2017)

Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed M. vaccae administered daily for one month

Por Bourinbaiar, Aldar S., Batbold, Uyanga, Efremenko, Yuri, Sanjagdorj, Munkhburam, Butov, Dmytro, Damdinpurev, Narantsetseg, Grinishina, Elena, Mijiddorj, Otgonbayar, Kovolev, Mikola, Baasanjav, Khaliunaa, Butova, Tetyana, Prihoda, Natalia, Batbold, Ochirbat, Yurchenko, Larisa, Tseveendorj, Ariungerel, Arzhanova, Olga, Chunt, Erkhemtsetseg, Stepanenko, Hanna, Sokolenko, Nina, Makeeva, Natalia, Tarakanovskaya, Marina, Borisova, Vika, Reid, Alan, Kalashnikov, Valeryi, Nyasulu, Peter, Prabowo, Satria A., Jirathitikal, Vichai, Bain, Allen I., Stanford, Cynthia, Stanford, John
Publicado no J Clin Tuberc Other Mycobact Dis (2019)